Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 7
1946 11
1947 17
1948 17
1949 26
1950 28
1951 40
1952 34
1953 27
1954 24
1955 40
1956 33
1957 43
1958 44
1959 52
1960 50
1961 53
1962 54
1963 65
1964 98
1965 71
1966 76
1967 83
1968 72
1969 90
1970 84
1971 96
1972 105
1973 110
1974 108
1975 75
1976 64
1977 76
1978 72
1979 77
1980 88
1981 69
1982 81
1983 106
1984 107
1985 162
1986 276
1987 328
1988 329
1989 405
1990 443
1991 443
1992 534
1993 500
1994 481
1995 488
1996 515
1997 498
1998 533
1999 525
2000 559
2001 548
2002 689
2003 637
2004 635
2005 661
2006 729
2007 791
2008 828
2009 890
2010 998
2011 1108
2012 1270
2013 1191
2014 1200
2015 1253
2016 1214
2017 1364
2018 1289
2019 1254
2020 1339
2021 1522
2022 1396
2023 1385
2024 1269
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31,863 results

Results by year

Filters applied: . Clear all
Page 1
Myelodysplastic Syndrome Updated.
Hasserjian RP. Hasserjian RP. Pathobiology. 2019;86(1):7-13. doi: 10.1159/000489702. Epub 2018 Jul 24. Pathobiology. 2019. PMID: 30041243 Free article. Review.
This review highlights the main changes in the revised 2016 WHO Classification of Myeloid Neoplasms (published in 2017) that impact the diagnosis and management of patients with myelodysplastic syndrome (MDS). The revision was based on data accumulated since the 200 …
This review highlights the main changes in the revised 2016 WHO Classification of Myeloid Neoplasms (published in 2017) that impact the diag …
Childhood Myelodysplastic Syndrome.
Chisholm KM, Bohling SD. Chisholm KM, et al. Clin Lab Med. 2023 Dec;43(4):639-655. doi: 10.1016/j.cll.2023.06.005. Epub 2023 Aug 7. Clin Lab Med. 2023. PMID: 37865508 Review.
Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...
Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...
The Molecular Pathology of Myelodysplastic Syndrome.
Haferlach T. Haferlach T. Pathobiology. 2019;86(1):24-29. doi: 10.1159/000488712. Epub 2018 May 23. Pathobiology. 2019. PMID: 29791902 Free article. Review.
The diagnosis and classification of myelodysplastic syndromes (MDS) are based on cytomorphology and cytogenetics (WHO classification). ...
The diagnosis and classification of myelodysplastic syndromes (MDS) are based on cytomorphology and cytogenetics (WHO classifi …
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.
Lee P, Yim R, Yung Y, Chu HT, Yip PK, Gill H. Lee P, et al. Int J Mol Sci. 2021 Sep 23;22(19):10232. doi: 10.3390/ijms221910232. Int J Mol Sci. 2021. PMID: 34638574 Free PMC article. Review.
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and predisposition to acute myeloid leukemia (AML). ...
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder characterized by ineffective hematopoiesis, c …
MYELODYSPLASTIC SYNDROME: DIAGNOSIS, TREATMENT AND PROGNOSIS (LITERATURE REVIEW).
Baidurin S, Akhmetzhanova S, Ilmalieva A, Sagyndykova G, Orazbekova A. Baidurin S, et al. Georgian Med News. 2023 Jan;(334):103-107. Georgian Med News. 2023. PMID: 36864802 Review.
The review article discusses the issues of terminology, pathogenesis, classification and diagnosis of myelodysplastic syndrome (MDS), as well as the principles of management of this category of patients. ...To improve the quality of life of patients with MDS, epigen …
The review article discusses the issues of terminology, pathogenesis, classification and diagnosis of myelodysplastic syndrome …
[Myelodysplastic syndrome : prognostic factors].
Gyan E, Thépot S. Gyan E, et al. Bull Cancer. 2023 Nov;110(11):1141-1146. doi: 10.1016/j.bulcan.2023.06.008. Epub 2023 Aug 1. Bull Cancer. 2023. PMID: 37537115 Review. French.
The prognostic evaluation of myelodysplastic syndromes has evolved considerably over time, both due to the evolution of diagnostic classifications and the improvement in the prediction of the outcome. ...
The prognostic evaluation of myelodysplastic syndromes has evolved considerably over time, both due to the evolution of diagno …
EnvIRONmental Aspects in Myelodysplastic Syndrome.
Petzer V, Theurl I, Weiss G, Wolf D. Petzer V, et al. Int J Mol Sci. 2021 May 14;22(10):5202. doi: 10.3390/ijms22105202. Int J Mol Sci. 2021. PMID: 34068996 Free PMC article. Review.
Systemic iron overload is multifactorial in patients suffering from myelodysplastic syndrome (MDS). Disease-immanent ineffective erythropoiesis together with chronic red blood cell transfusion represent the main underlying reasons. ...
Systemic iron overload is multifactorial in patients suffering from myelodysplastic syndrome (MDS). Disease-immanent ineffecti …
Pediatric Myelodysplastic Syndromes.
Patel SS. Patel SS. Clin Lab Med. 2021 Sep;41(3):517-528. doi: 10.1016/j.cll.2021.03.015. Epub 2021 Jun 24. Clin Lab Med. 2021. PMID: 34304779 Review.
Pediatric myelodysplastic syndromes (MDS) comprise less than 5% of childhood malignancies. Approximately 30% to 45% of pediatric MDS cases are associated with an underlying genetic predisposition syndrome. ...
Pediatric myelodysplastic syndromes (MDS) comprise less than 5% of childhood malignancies. Approximately 30% to 45% of pediatr …
Familial myelodysplastic syndrome/acute myeloid leukemia.
Churpek JE. Churpek JE. Best Pract Res Clin Haematol. 2017 Dec;30(4):287-289. doi: 10.1016/j.beha.2017.10.002. Epub 2017 Oct 4. Best Pract Res Clin Haematol. 2017. PMID: 29156196 Free PMC article. Review.
A growing number of inherited genetic loci that contribute to myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) development in both children as well as adults are rapidly being identified. ...
A growing number of inherited genetic loci that contribute to myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) develo …
Therapy-related myelodysplastic syndrome.
Candelaria M, Dueñas-Gonzalez A. Candelaria M, et al. Expert Opin Drug Saf. 2015 May;14(5):655-65. doi: 10.1517/14740338.2015.1014340. Epub 2015 Feb 12. Expert Opin Drug Saf. 2015. PMID: 25675961 Review.
INTRODUCTION: Myelodysplastic syndrome (MDS) is a heterogeneous clonal disorder characterized by deregulation of apoptosis, dysplastic features in hematopoietic precursors, peripheral blood cytopenias and an increased risk for transformation to acute leukemia. ...
INTRODUCTION: Myelodysplastic syndrome (MDS) is a heterogeneous clonal disorder characterized by deregulation of apoptosis, dy …
31,863 results
You have reached the last available page of results. Please see the User Guide for more information.